“Atrial fibrillation is the most common cardiac arrhythmia in the United States,” said Paul A. Heidenreich, MD, professor at Stanford (Calif.) University School of Medicine and chair of the writing committee that developed the new recommendations. “This condition impacts between 2.7 million and 6.1 million American adults, and this number is expected to double by 2050. Updating the measure set was a priority for the ACC and AHA.”
The new update increases the scope of the recommendations beyond the outpatient setting to include the inpatient setting as well. Healthcare domains newly addressed in the update include patient safety, effective clinical care, communication and coordination of care.
“The writing committee believes that implementation of this clinical performance and quality measure set by providers, physician practices, and hospital systems will help to enhance the quality of care provided to patients with atrial fibrillation in both the inpatient and outpatient settings, and thereby improve their quality of life,” said Dr. Heidenreich.
The new measures can be found in the Journal of the American College of Cardiology.
More articles on quality:
Anthrax can shrink cancer tumors, scientists find
After patient suicide, group wants Bridgewater State Hospital management to change hands
3 ways to make chemo more tolerable
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
